Myocardial triglyceride content at 3 T cardiovascular magnetic resonance and left ventricular systolic function: a cross-sectional study in patients hospitalized with acute heart failure

Table 2 CMR imaging data of the study participants

	HF patients with low LVEF	HF patients with normal LVEF	Control subjects	p value
	(n = 25)	(n = 23)	(n = 21)	p value
LV ejection fraction (%)	31.2 ± 12.3^{, *}	60.2 ± 8.3 ^*	70.9 ± 7.6	<0.001
LV end-diastolic volume (mL)	169.5 ± 78.1^,^*	124 ± 43.7 ^*	95.3 ± 23.4	< 0.001
LV end-systolic volume (mL)	120.8 ± 70.7^,^*	51.2 ± 24.0 ^*	28.2 ± 11.5	< 0.001
Stroke volume (mL)	48.7 ± 19.4^,^*	72.8 ± 22.4	67.2 ± 15.9	< 0.001
Cardiac output (L/min)	3.7 ± 1.5^,^*	4.8 ± 1.5	5.1 ± 1.1	0.004
LV mass (g)	126.1 ± 52.9^*	113.5 ± 34.8 ^*	94.4 ± 23.2	0.032
LV global function index (%)	20.2 ± 9.0^,^*	37.6 ± 6.7 ^*	44.6 ± 6.1	< 0.001
LV concentricity	0.8 ± 0.3^,^*	1.0 ± 0.4	1 ± 0.3	0.027

Data are expressed as means ± standard deviations. P values are calculated from one-way analysis of variance
Abbreviations: HF heart failure, LV left ventricle, LVEF left ventricular ejection fraction
^* p < 0.05 vs. controls; ^** p < 0.05 vs. HF patients with normal LVEF

ISSN: 1532-429X